<iframe src="//www.googletagmanager.com/ns.html?id=GTM-K3L4M3" height="0" width="0" style="display:none;visibility:hidden">

World

What we don't (yet) know about the Oxford vaccine

21 July 2020

3:09 AM

21 July 2020

3:09 AM

How excited should we be about the latest news of the Oxford vaccine? At least this time – in contrast to previous updates, which have tended to come via Downing Street briefings – we have a paper in a scientific journal, the Lancet, to go by. The paper reports that 1,077 people took part in the trial and that 90 per cent developed antibodies to the SARS-CoV-2 virus after a single dose of the vaccine.

Already a subscriber? Log in

Easter flash sale:
10 issues for $1

Subscribe this Easter and get the next 10 issues of the magazine, plus website and app access, all for just $1.

  • Weekly delivery of the magazine
  • Unlimited access to spectator.com.au and app
  • Spectator Australia podcasts and newsletters
  • Full access to spectator.co.uk
Or

Unlock 3 articles a month

REGISTER


Comments

Easter flash sale: 10 issues for $1

Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.

Already a subscriber? Log in

Close